DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Browse Other Languages
YouTube - Featured Content

Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here

epgonline.org is not responsible for content on any 3rd party website

Male hypogonadism is the term used to describe decreased functional activity of the testes with diminished production and action of testosterone. Benign prostatic hyperplasia is a progressive disease defined histologically and characterized by stromal and epithelial cell hyperplasia beginning in the periurethral zone of the prostate. Parkinson's disease (PD) is a degenerative disorder of the central nervous system characterized by the clinically asymmetric onset of resting tremor, bradykinesia, rigidity and postural instability. Calendar of this months Global and European Medical conferences in Healthcare
Are you a Doctor or Healthcare Professional? Authorise Viewing

Please register to access disease diagnosis, patient management, physician tools.

By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: United Kingdom

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M
N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

Medicine information : Famotidine (Generic)
 
Drug class description :  H2 -antagonists (H2 -receptor antagonists / H 2 -blockers).
Generic Name :  Generic
Drug description :  Tablets.
Presentation :  Tablets, famotidine 20mg , 40mg . Available from APS, Hillcross, Lagap, Norton.
Indications :  Duodenal and benign gastric ulcers. Prevention of relapse of duodenal ulceration. Zollinger- Ellison syndrome. Prevention and treatment of gastro-oesophageal reflux disease.
Adult Dosage :  Benign gastric and duodenal ulcer, 40 mg at night for four to eight weeks. Prophylaxis of duodenal ulcer relapse, 20 mg at night. Zollinger-Ellison syndrome, initially, 20 mg every six hours, adjust as necessary; maximum 800 mg daily. Gastro-oesophageal reflux disease, 20 mg twice daily for six to 12 weeks; if also erosion six to 12 weeks; if also erosion or ulceration, 40 mg twice daily for six to 12 weeks. Prophylaxis 20 mg twice daily.
Child Dosage :  Not recommended.
Contra Indications :  Hypersensitivity to any component.
Special Precautions :  Impaired renal function, gastric carcinoma. Pregnancy, lactation.
Adverse Reactions :  Headache, dizziness, CNS disturbances, dry mouth, constipation, diarrhoea, nausea, rash, GI discomfort, anorexia, fatigue, arthralgia, muscle cramps, liver enzyme abnormalities. Rarely, reversible gynaecomastia, toxic epidermal necrolysis.
Drug Availability :  (POM)
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.

Already Registered?

Please log-in now using our member login box.

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

What's New!
Try EPG Mobile
Latest News
Disease Knowledge Centres

EPG Survey Become a member of
the new EPG Survey Panel.
Your opinions matter, get paid for them! Join Now!